Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
(Q)SAR
Adequacy of study:
weight of evidence
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
results derived from a valid (Q)SAR model and falling into its applicability domain, with adequate and reliable documentation / justification
Justification for type of information:
1. SOFTWARE

-ACD/Percepta

2. MODEL

- Advanced chemistry devlopmnent, INc.; Pharma Algorithms, Inc., Version 2016

3. SMILES OR OTHER IDENTIFIERS USED AS INPUT FOR THE MODEL

O=C(C1N(C)CC(CCC)C1)NC(C2OC(SC)C(O)C3C2OC(C)(C)O3)C(Cl)C

4. SCIENTIFIC VALIDITY OF THE (Q)SAR MODEL

This above mentioned tool was selected according to the OECD Guidance Documents on the Validation of (Q)SAR models:

- Document on the validation of (Quantitative) Structure Activity Relationship models. OECD Series on testing and Assessment N° 69. ENV/JM/MONO(2007)2.

5. APPLICABILITY DOMAIN

ACD/Percepta : Reliability Index (RI) from 0 (not reliable) to 1(fully reliable)

6. ADEQUACY OF THE RESULT

ACD/Percepta: oral toxicity on rat: moderate reliable

from the evaluation of result, the target compound was predicted to be orally toxic on rat and the final predisction was assessed as moderate reliable.

Data source

Reference
Title:
Unnamed
Year:
2017
Report date:
2017

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
other: OECD series on testing and assessment n°69
Version / remarks:
ENV/JM/MONO(2007)2
Deviations:
not specified

Test material

Constituent 1
Chemical structure
Reference substance name:
(2S,4R)-N-[(1S,2S)-1-[(3aS,4R,6R,7R,7aR)-7-hydroxy-2,2-dimethyl-6-(methylsulfanyl)-hexahydro-[1,3]dioxolo[4,5-c]pyran-4-yl]-2-chloropropyl]-1-methyl-4-propylpyrrolidine-2-carboxamide
EC Number:
604-595-3
Cas Number:
147650-54-2
Molecular formula:
C21H37ClN2O5S
IUPAC Name:
(2S,4R)-N-[(1S,2S)-1-[(3aS,4R,6R,7R,7aR)-7-hydroxy-2,2-dimethyl-6-(methylsulfanyl)-hexahydro-[1,3]dioxolo[4,5-c]pyran-4-yl]-2-chloropropyl]-1-methyl-4-propylpyrrolidine-2-carboxamide

Test animals

Species:
rat
Strain:
not specified
Remarks:
this is a (Q)SAR in silico study
Sex:
not specified

Administration / exposure

Route of administration:
oral: unspecified
Vehicle:
not specified
Remarks:
this is a (Q)SAR in silico study
Control animals:
not specified

Results and discussion

Effect levels
Sex:
not specified
Dose descriptor:
LD50
Effect level:
ca. 420 other: mg/kg
Based on:
other: (Q)SAR in silico prediction

Any other information on results incl. tables

This study was designed to generate estimated "in silico" (non-testing) data to be used for the hazard assessment of the substance.

The table below shows the result obtained.

 Endpoint  Prediction call  Reliability Assessment
 Acute oral toxicity (rat)  LD50 = 420 mg/kg  Moderate reliable

Applicant's summary and conclusion

Interpretation of results:
Category 1 based on GHS criteria
Conclusions:
ACUTE ORAL TOXICITY

prediction call: LD50= 420 mg/kg
reliability assesssment: moderate reliable
Executive summary:

The acute oral toxicity of the target compound was predicted employing ACD/Percepta model that provides LD50 predictions for rat by oral administration routes, based on the GALAS methodology. Estimation of the RI takes into account two aspects: similarity of the tested compound to the training and the consistency of experimental values for similar compounds. In the weight of evidence assessment only reliable predictions are to be taken into account. In the case of the target methyl 7-chloro-6,7,8- trideoxy-3,4-O-isopropylidene-6-{[(4R)-1-methyl-4-propyl-L-propyl]amino}-1-thio-L-threo-α-D-galacto-octopyranoside ACD/Percepta provided an LD50 prediction equal to 420 mg/kg so the prediction is assessed as moderate reliable.